The market for organ preservation solutions is driven by rising transplant surgeries due to chronic illnesses and aging ...
Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...
The "rapid recovery with extended ultraoxygenated preservation" (REUP) technique, which does not require pre-implant donor ...
The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...
Normothermic machine perfusion (NMP) to preserve livers prior to transplant was associated with significantly improved clinical outcomes and reduced use of hospital resources compared with static cold ...
A clinical study shows that preoperative dynamic susceptibility contrast (DSC) perfusion magnetic resonance imaging (MRI) can ...
Potential for improved product quality and cost/time savings is reviving interest in perfusion technology. Tuomas Kujansuu/E+/Getty Images Perfusion technology was first introduced in the late 1980s ...
Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results